HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.

about

HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.

Item

http://www.wikidata.org/entity/Q55223142

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@en

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@nl

type

Item

label

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@en

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@nl

prefLabel

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@en

HPV-16 E7 expression up-regula ...... nce in a pRB-dependent manner.

@nl

P1476

HPV-16 E7 expression up-regula ...... ance in a pRB-dependent manner

@en

P2093

Iolanda Midea Cuccovia

http://www.w3.org/2001/XMLSchema#string

Katia Regina Perez

http://www.w3.org/2001/XMLSchema#string

Luisa Lina Villa

http://www.w3.org/2001/XMLSchema#string

Rubiana Andrade

http://www.w3.org/2001/XMLSchema#string

Suely Nonogaki

http://www.w3.org/2001/XMLSchema#string

P2860

Phospholipase D in cell proliferation and cancer

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes

Case-control study of human papillomavirus and oropharyngeal cancer

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

TRANSFAC: an integrated system for gene expression regulation.

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.

Rapamycin inhibits anal carcinogenesis in two preclinical animal models.

P2888

s12885-018-4392-8

P304

485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4392-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Boccardo

Tatiana Rabachini

P577

2018-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103671273

http://www.w3.org/2001/XMLSchema#string

P698

29703186

http://www.w3.org/2001/XMLSchema#string

P932

5923196

http://www.w3.org/2001/XMLSchema#string